- Home
- MCVT vs ADXN Comparison
MCVT vs ADXN Comparison
Compare MCVT & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCVT
- ADXN
- Stock Information
- Founded
- MCVT 2007
- ADXN 2002
- Country
- MCVT United States
- ADXN Switzerland
- Employees
- MCVT N/A
- ADXN N/A
- Industry
- MCVT Finance Companies
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- MCVT Finance
- ADXN Health Care
- Exchange
- MCVT Nasdaq
- ADXN Nasdaq
- Market Cap
- MCVT 9.3M
- ADXN 8.1M
- IPO Year
- MCVT N/A
- ADXN N/A
- Fundamental
- Price
- MCVT $1.83
- ADXN $9.00
- Analyst Decision
- MCVT
- ADXN Strong Buy
- Analyst Count
- MCVT 0
- ADXN 1
- Target Price
- MCVT N/A
- ADXN $30.00
- AVG Volume (30 Days)
- MCVT 16.1K
- ADXN 10.6K
- Earning Date
- MCVT 08-13-2025
- ADXN 06-19-2025
- Dividend Yield
- MCVT N/A
- ADXN N/A
- EPS Growth
- MCVT N/A
- ADXN N/A
- EPS
- MCVT 0.19
- ADXN 0.10
- Revenue
- MCVT $3,246,479.00
- ADXN $278,508.00
- Revenue This Year
- MCVT N/A
- ADXN $86.57
- Revenue Next Year
- MCVT N/A
- ADXN N/A
- P/E Ratio
- MCVT $9.65
- ADXN $0.75
- Revenue Growth
- MCVT N/A
- ADXN N/A
- 52 Week Low
- MCVT $1.13
- ADXN $6.51
- 52 Week High
- MCVT $3.88
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- MCVT 50.24
- ADXN 55.39
- Support Level
- MCVT $1.77
- ADXN $8.02
- Resistance Level
- MCVT $1.91
- ADXN $9.78
- Average True Range (ATR)
- MCVT 0.08
- ADXN 0.73
- MACD
- MCVT -0.01
- ADXN 0.02
- Stochastic Oscillator
- MCVT 36.11
- ADXN 32.94
About MCVT Mill City Ventures III Ltd.
Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.